RxDoctor Payments DataLook up a doctor →

Herbert Cordero Yordan, MD

Cardiovascular Disease · Las Vegas, NVNPI 1619924602

Payments from drug & device makers

$38,030in general payments, 2019–2025

Across 971 payments — averaging $39.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$5K
  • Medtronic$5K
  • W. L. Gore & Associates, Inc.$5K
  • Shockwave Medical, Inc$4K
  • Abbott$3K
  • Boston Scientific$2K
  • plus $14K from 54 others
$124in research payments, 2019–2025

Across 1 payment — averaging $124.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$124

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abiomed131$5,477
Medtronic(2 entities)58$5,234
W. L. Gore & Associates, Inc.97$5,109
Shockwave Medical, Inc63$3,506
Abbott33$2,972
Boston Scientific36$1,547
Novartis75$1,454
Cvrx, Inc.23$1,160
Amgen100$1,029
Johnson & Johnson47$890
Asahi Intecc USA, Inc.17$829
Terumo Medical Corporation31$720
Surmodics, Inc.7$716
Philips North America LLC23$639
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)31$570
E.r. Squibb & Sons, L.L.C.33$547
Penumbra, Inc.4$462
Merck23$443
Bayer17$329
Angiodynamics, Inc.4$307
Bolton Medical Inc9$299
Novo Nordisk15$299
Inspire Medical Systems, Inc.4$255
Cordis US CORP.3$250
Bard Peripheral Vascular, Inc.7$250
Endologix LLC1$231
Baylis Medical Company Inc1$214
Kiniksa Pharmaceuticals International, PLC7$194
Edwards Lifesciences7$161
Silk Road Medical, Inc.2$153
Acist Medical Systems, Inc.1$140
Siemens Medical Solutions USA, Inc.3$136
Teleflex LLC6$114
Merit Medical Systems Inc1$110
Bridgebio Pharma, Inc.3$109
Roche Diagnostics Corporation1$108
Kestra Medical Technology Services, Inc.4$99
Heartflow, Inc.1$98
AstraZeneca5$93
Lexicon Pharmaceuticals, Inc.5$93
Cardiovascular Systems Inc.5$93
La Jolla Pharmaceutical Company2$84
Pfizer3$61
Viatris Specialty LLC2$43
Inogen, Inc.2$39
Alnylam Pharmaceuticals Inc.1$35
Azurity Pharmaceuticals, Inc.2$31
Regeneron Healthcare Solutions, Inc.1$31
Boehringer Ingelheim1$28
Davol Inc.1$27
Verona Pharma, Inc.1$26
Actelion Pharmaceuticals US, Inc.1$24
GSK1$22
Cardiva Medical, Inc.1$20
Esperion Therapeutics, Inc.1$20
Amarin Pharma, Inc.1$17
Sanofi-aventis U.S. LLC1$17
Sanofi1$16
Kiniksa Pharmaceuticals, Ltd.1$15
Smith+Nephew1$15

How this compares

$38,030 in reported general payments places this provider in the 85th percentile of 165 cardiovascular disease providers in Nevada.

See all cardiovascular disease providers in Nevada →

Medicare billing

Part B allowed, 2024
$754,021
Medicare patients
757
Services billed
4,165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Las Vegas

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →